XML 36 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
EARNINGS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2016
Earnings Per Share, Basic and Diluted [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The computation of basic and diluted earnings per common share was as follows:

 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Amounts attributable to Quest Diagnostics’ stockholders:
 

 
 

 
 

 
 

Net income attributable to Quest Diagnostics
$
192

 
$
342

 
$
490

 
$
521

Less: Earnings allocated to participating securities
2

 
2

 
3

 
3

Earnings available to Quest Diagnostics’ common stockholders – basic and diluted
$
190

 
$
340

 
$
487

 
$
518

 
 
 
 
 
 
 
 
Weighted average common shares outstanding – basic
139

 
144

 
141

 
144

Effect of dilutive securities:
 

 
 

 
 

 
 

Stock options and performance share units
3

 
1

 
2

 
1

Weighted average common shares outstanding – diluted
142

 
145

 
143

 
145

 
 
 
 
 
 
 
 
Earnings per share attributable to Quest Diagnostics’ common stockholders:
 

 
 

 
 

 
 

Basic
$
1.37

 
$
2.37

 
$
3.46

 
$
3.61

 
 
 
 
 
 
 
 
Diluted
$
1.34

 
$
2.35

 
$
3.42

 
$
3.58

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
Stock options and performance share units

 
2

 
1

 
2